IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANIKA R WEBB

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1811390560
CMS profile
10581550
Location
TROY, PA

General Payments · PY2021–2024

$4,489.46

  • Reported across 271 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,025.34

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Medical PA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,025.34 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $182.80 7
ITI, Inc. $142.72 7
ABBVIE INC. $133.34 7
ANI Pharmaceuticals, Inc. $83.65 3
Lilly USA, LLC $76.71 4
Axsome Therapeutics, Inc. $71.88 4
Amgen Inc. $65.53 4
Takeda Pharmaceuticals U.S.A., Inc. $60.22 4
Lundbeck LLC $45.90 2
Novo Nordisk AS $29.39 2
Otsuka America Pharmaceutical, Inc. $27.25 1
DePuy Synthes Sales Inc. $21.23 1
Antares Pharma, Inc. $20.14 1
Ferring Pharmaceuticals Inc. $20.07 1
PFIZER INC. $15.73 1
Paratek Pharmaceuticals, Inc. $15.27 1
Bayer HealthCare Pharmaceuticals Inc. $13.51 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,078.91 78
PY2022 $1,121.38 73
PY2023 $1,263.83 69
PY2024 $1,025.34 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $15.76 01/24/2024 Food and Beverage Undisputed 01/23/2026 1108388221 CMS
ABBVIE INC. $12.78 03/08/2024 Food and Beverage Undisputed 01/23/2026 1108388223 CMS
ABBVIE INC. $12.45 04/30/2024 Food and Beverage Undisputed 01/23/2026 1108388225 CMS
ABBVIE INC. $15.89 05/13/2024 Food and Beverage Undisputed 01/23/2026 1108388227 CMS
ABBVIE INC. $23.91 06/05/2024 Food and Beverage Undisputed 01/23/2026 1108388229 CMS
ABBVIE INC. $34.67 07/24/2024 Food and Beverage Undisputed 01/23/2026 1108388231 CMS
ABBVIE INC. $17.88 10/17/2024 Food and Beverage Undisputed 01/23/2026 1108388233 CMS
Amgen Inc. $16.84 03/14/2024 Food and Beverage Undisputed 01/23/2026 1117714880 CMS
Amgen Inc. $18.31 05/06/2024 Food and Beverage Undisputed 01/23/2026 1117714882 CMS
Amgen Inc. $15.81 06/21/2024 Food and Beverage Undisputed 01/23/2026 1117714884 CMS
Amgen Inc. $14.57 11/11/2024 Food and Beverage Undisputed 01/23/2026 1117714886 CMS
ANI Pharmaceuticals, Inc. $32.47 07/24/2024 Food and Beverage Undisputed 01/23/2026 1091141966 CMS
ANI Pharmaceuticals, Inc. $30.87 08/29/2024 Food and Beverage Undisputed 01/23/2026 1091142446 CMS
ANI Pharmaceuticals, Inc. $20.31 11/19/2024 Food and Beverage Undisputed 01/23/2026 1091154766 CMS
Antares Pharma, Inc. $20.14 10/03/2024 Food and Beverage Undisputed 01/23/2026 1146527051 CMS
AstraZeneca Pharmaceuticals LP $91.29 02/01/2024 Food and Beverage Undisputed 01/23/2026 1105549868 CMS
AstraZeneca Pharmaceuticals LP $17.08 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105701560 CMS
AstraZeneca Pharmaceuticals LP $14.87 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105562638 CMS
AstraZeneca Pharmaceuticals LP $14.63 04/29/2024 Food and Beverage Undisputed 01/23/2026 1104231765 CMS
AstraZeneca Pharmaceuticals LP $16.22 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104645393 CMS
AstraZeneca Pharmaceuticals LP $15.33 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105877807 CMS
AstraZeneca Pharmaceuticals LP $13.38 10/28/2024 Food and Beverage Undisputed 01/23/2026 1104327478 CMS
Axsome Therapeutics, Inc. $23.76 01/11/2024 Food and Beverage Undisputed 01/23/2026 1148336409 CMS
Axsome Therapeutics, Inc. $16.93 02/15/2024 Food and Beverage Undisputed 01/23/2026 1148336407 CMS
Axsome Therapeutics, Inc. $17.30 03/25/2024 Food and Beverage Undisputed 01/23/2026 1148336411 CMS
Axsome Therapeutics, Inc. $13.89 12/09/2024 Food and Beverage Undisputed 01/23/2026 1148336413 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.51 01/29/2024 Food and Beverage Undisputed 01/23/2026 1086345605 CMS
DePuy Synthes Sales Inc. $21.23 06/06/2024 Food and Beverage Undisputed 01/23/2026 1077887166 CMS
Ferring Pharmaceuticals Inc. $20.07 11/04/2024 Food and Beverage Undisputed 01/23/2026 1137548272 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.78 01/03/2024 Food and Beverage Undisputed 01/23/2026 1143625628 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.65 03/20/2024 Food and Beverage Undisputed 01/23/2026 1143625630 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.96 05/23/2024 Food and Beverage Undisputed 01/23/2026 1143625632 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.93 08/22/2024 Food and Beverage Undisputed 01/23/2026 1143625634 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.66 10/14/2024 Food and Beverage Undisputed 01/23/2026 1143625636 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.10 10/14/2024 Food and Beverage Undisputed 01/23/2026 1143625638 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.64 12/12/2024 Food and Beverage Undisputed 01/23/2026 1143625640 CMS
Lilly USA, LLC $23.40 01/24/2024 Food and Beverage Undisputed 01/23/2026 1135529137 CMS
Lilly USA, LLC $18.24 03/28/2024 Food and Beverage Undisputed 01/23/2026 1135448135 CMS
Lilly USA, LLC $18.30 04/22/2024 Food and Beverage Undisputed 01/23/2026 1135516306 CMS
Lilly USA, LLC $16.77 07/29/2024 Food and Beverage Undisputed 01/23/2026 1135516304 CMS
Lundbeck LLC $27.17 02/11/2024 Food and Beverage Undisputed 01/23/2026 1146105305 CMS
Lundbeck LLC $18.73 05/31/2024 Food and Beverage Undisputed 01/23/2026 1146105307 CMS
Novo Nordisk Inc $14.95 04/09/2024 Food and Beverage Undisputed 01/23/2026 1100356016 CMS
Novo Nordisk Inc $14.44 04/09/2024 Food and Beverage Undisputed 01/23/2026 1100648609 CMS
Otsuka America Pharmaceutical, Inc. $27.25 09/06/2024 Food and Beverage Undisputed 01/23/2026 1119211191 CMS
Paratek Pharmaceuticals, Inc. $15.27 10/07/2024 Food and Beverage Undisputed 01/23/2026 1113935424 CMS
PFIZER INC. $15.73 08/11/2024 Food and Beverage Undisputed 01/23/2026 1131829633 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.81 02/05/2024 Food and Beverage Undisputed 01/23/2026 1137841795 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.22 10/21/2024 Food and Beverage Undisputed 01/23/2026 1137841797 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.95 11/18/2024 Food and Beverage Undisputed 01/23/2026 1137841799 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.24 12/16/2024 Food and Beverage Undisputed 01/23/2026 1137841801 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.